Optimizing valve placement during TAVI
Part of Heart & circulation clinical trials.
This trial is testing a better way to position a new heart valve during a TAVI procedure. The goal is to help the valve work as well as possible for people with severe aortic stenosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe narrowing of your aortic heart valve (the main valve that pumps blood to your body).
- Your doctor has decided a TAVI procedure (a less invasive valve replacement) is right for you.
- You are not taking a blood thinner for conditions like atrial fibrillation or a blood clot.
- Your kidneys are working well enough (not on dialysis and with a creatinine clearance above 15).
- You can safely have a CT scan of your heart (no allergy to iodine contrast dye).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether expanding the new heart valve in a more symmetric way after TAVI (a procedure to replace a narrowed heart valve) can reduce the risk of blood clots forming on the valve leaflets. It may help keep the new valve working well over time.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
This study looks at two different ways of expanding a new heart valve during a minimally invasive procedure called TAVI. It aims to find out which method gives the best fit and function of the valve in people with severe aortic stenosis (a narrowed heart valve).
This study tests whether a more precise way of aligning the replacement valve during a minimally invasive aortic valve procedure improves outcomes. It may help people with severe aortic stenosis get a longer-lasting, better-functioning valve.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study is looking at how well doctors can reach the coronary arteries (the blood vessels that supply the heart muscle) after a TAVI procedure using the Evolut FX Plus valve. It may help improve future procedures for people with severe aortic stenosis.
Hear when a new Aortic Stenosis Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.